MX354758B - Metodos para la liberacion de las particulas similares a virus. - Google Patents

Metodos para la liberacion de las particulas similares a virus.

Info

Publication number
MX354758B
MX354758B MX2015010566A MX2015010566A MX354758B MX 354758 B MX354758 B MX 354758B MX 2015010566 A MX2015010566 A MX 2015010566A MX 2015010566 A MX2015010566 A MX 2015010566A MX 354758 B MX354758 B MX 354758B
Authority
MX
Mexico
Prior art keywords
particles
release
methods
virus
vlp
Prior art date
Application number
MX2015010566A
Other languages
English (en)
Other versions
MX2015010566A (es
Inventor
Vicky Fachinger
Melanie Sno
Original Assignee
Intervet Int Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47749649&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX354758(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Intervet Int Bv filed Critical Intervet Int Bv
Publication of MX2015010566A publication Critical patent/MX2015010566A/es
Publication of MX354758B publication Critical patent/MX354758B/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • A61K2039/5258Virus-like particles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/14011Baculoviridae
    • C12N2710/14041Use of virus, viral particle or viral elements as a vector
    • C12N2710/14043Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vectore
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011Details
    • C12N2750/10011Circoviridae
    • C12N2750/10023Virus like particles [VLP]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011Details
    • C12N2750/10011Circoviridae
    • C12N2750/10051Methods of production or purification of viral material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011Details
    • C12N2750/14011Parvoviridae
    • C12N2750/14023Virus like particles [VLP]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011Details
    • C12N2750/14011Parvoviridae
    • C12N2750/14051Methods of production or purification of viral material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011Details
    • C12N2750/14011Parvoviridae
    • C12N2750/14311Parvovirus, e.g. minute virus of mice
    • C12N2750/14323Virus like particles [VLP]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011Details
    • C12N2750/14011Parvoviridae
    • C12N2750/14311Parvovirus, e.g. minute virus of mice
    • C12N2750/14351Methods of production or purification of viral material

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Cell Biology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

La presente invención se refiere a los métodos para la liberación de las Partículas similares a Virus (VLP) expresado en baculovirus de virus no encapsulado a partir de células de insecto.
MX2015010566A 2013-02-15 2014-02-14 Metodos para la liberacion de las particulas similares a virus. MX354758B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP13155370 2013-02-15
PCT/EP2014/052870 WO2014125053A1 (en) 2013-02-15 2014-02-14 Methods for the release of virus-like particles

Publications (2)

Publication Number Publication Date
MX2015010566A MX2015010566A (es) 2015-11-16
MX354758B true MX354758B (es) 2018-03-20

Family

ID=47749649

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2015010566A MX354758B (es) 2013-02-15 2014-02-14 Metodos para la liberacion de las particulas similares a virus.

Country Status (12)

Country Link
US (2) US9193759B2 (es)
EP (1) EP2956167B1 (es)
JP (1) JP6475641B2 (es)
KR (1) KR102071751B1 (es)
CN (1) CN105073131B (es)
BR (1) BR112015019619A2 (es)
CA (1) CA2899682C (es)
ES (1) ES2606040T3 (es)
HU (1) HUE031502T2 (es)
MX (1) MX354758B (es)
RU (1) RU2648143C2 (es)
WO (1) WO2014125053A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB202007246D0 (en) * 2020-05-15 2020-07-01 Map Ip Holding Ltd Sample preparation and analysis methods
CN114250259B (zh) * 2020-09-21 2024-07-19 成都史纪生物制药有限公司 一种猪圆环2型病毒Cap蛋白病毒样颗粒的发酵培养基
KR20240104204A (ko) * 2021-12-27 2024-07-04 덴카 주식회사 바큘로바이러스 발현계에 있어서의 단백질의 제조법
WO2024203942A1 (ja) * 2023-03-24 2024-10-03 デンカ株式会社 バキュロウイルス発現ベクターシステムにおける遺伝子組換えタンパク質の製造方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040063188A1 (en) 2002-02-14 2004-04-01 Novavax, Inc. Kit for treating gastrointestinal tract
WO2010062757A1 (en) * 2008-11-03 2010-06-03 Ligocyte Pharmaceuticals, Inc. Improved methods for isolating enveloped virus-based vlps free of infectious agents
US9580474B2 (en) 2010-09-08 2017-02-28 The Johns Hopkins University Polyionic papilloma virus-like particle (VLP) vaccines

Also Published As

Publication number Publication date
EP2956167A1 (en) 2015-12-23
JP6475641B2 (ja) 2019-02-27
WO2014125053A1 (en) 2014-08-21
KR20150116854A (ko) 2015-10-16
CA2899682A1 (en) 2014-08-21
ES2606040T3 (es) 2017-03-17
MX2015010566A (es) 2015-11-16
EP2956167B1 (en) 2016-10-19
RU2648143C2 (ru) 2018-03-22
JP2016508720A (ja) 2016-03-24
HUE031502T2 (en) 2017-07-28
US9193759B2 (en) 2015-11-24
CN105073131B (zh) 2017-06-27
CN105073131A (zh) 2015-11-18
KR102071751B1 (ko) 2020-01-30
US20140234900A1 (en) 2014-08-21
CA2899682C (en) 2022-06-21
BR112015019619A2 (pt) 2017-07-18
US20150376577A1 (en) 2015-12-31
RU2015139154A (ru) 2017-03-21

Similar Documents

Publication Publication Date Title
EP3240551A4 (en) Methods of treating hematological disorders, solid tumors, or infectious diseases using natural killer cells
EA201790630A1 (ru) Способы получения рибозидов
SG11201404014PA (en) Methods for increasing the infectivity of viruses
SG11201404361UA (en) Methods for increasing the infectivity of viruses
PH12015501017A1 (en) Alternative uses for hbv assembly effectors
IL251532B (en) Modified virus-like cmv particles
EA201690372A1 (ru) Азапиридоновые соединения и их применение
EA201590868A1 (ru) Противовирусные соединения
AR091538A1 (es) Purificacion de particulas tipo virus
EA201790963A1 (ru) Противовирусные соединения
EA201691216A1 (ru) Композиции линаклотида с замедленным высвобождением
LT3355915T (lt) Panašių į šunų parvoviruso (cpv) virusinių dalelių (vlp) vakcinos ir jų panaudojimas
ZA202403393B (en) Synthetic chimeric poxviruses
MX2015011529A (es) Reordenamiento del virus de infuenza b.
PH12015502146A1 (en) 4-amino-6-(4-substituted-phenyl)-picolinates and 6-amino-2-(4-substituted-phenyl)-pyrimidine-4-carboxylates and their use as herbicides
CL2019002133A1 (es) Partícula similar a virus (vlp).
EP2968518A4 (en) VIRAL TYPE PARTICLES BASED ON PALIVIZUMAB EPITOPE
EA201692034A1 (ru) Новые макроциклические соединения
UY34420A (es) ?métodos de tratamiento del virus de la hepatitis c con que de gs-7977 y ribavirina, composiciones y usos"
EP3212672A4 (en) Methods and compositions for recombinant dengue viruses for vaccine and diagnostic development
MX2019007252A (es) Metodos y composiciones para vacunas del virus del dengue.
MX2015010566A (es) Metodos para la liberacion de las particulas similares a virus.
CL2015001738A1 (es) Partículas derivadas de virus no-replicativos y usos de los mismos
MX2015009330A (es) Reordenamiento del virus de influenza.
PL2992005T3 (pl) Zmutowane białko wypustek rozszerzające tropizm tkankowy wirusa zakaźnego zapalenia oskrzeli (IBV)

Legal Events

Date Code Title Description
FG Grant or registration